Cargando…

Correction: Identification of Ovarian Cancer Metastatic miRNAs

Detalles Bibliográficos
Autores principales:	Vang, Souriya, Wu, Hsin-Ta, Fischer, Andrew, Miller, Daniel H., MacLaughlan, Shannon, Douglass, Elijah, Steinhoff, Margaret, Collins, Colin, Smith, Peter J. S., Brard, Laurent, Brodsky, Alexander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880241/ http://dx.doi.org/10.1371/annotation/aeb6ccee-921a-4250-a18c-4ea633b984dd

Ejemplares similares

Identification of Ovarian Cancer Metastatic miRNAs
por: Vang, Souriya, et al.
Publicado: (2013)

Expression Profiling of Primary and Metastatic Ovarian Tumors Reveals Differences Indicative of Aggressive Disease
por: Brodsky, Alexander S., et al.
Publicado: (2014)

Leadership aspirations among residents in obstetrics and gynecology in the United States: a cross-sectional analysis
por: Bavan, Brindha, et al.
Publicado: (2019)

Integrated genomics of ovarian xenograft tumor progression and chemotherapy response
por: Stuckey, Ashley, et al.
Publicado: (2011)

HE4 (WFDC2) gene overexpression promotes ovarian tumor growth
por: Moore, Richard G., et al.
Publicado: (2014)

Bithionol inhibits ovarian cancer cell growth In Vitro - studies on mechanism(s) of action
por: Ayyagari, Vijayalakshmi N, et al.
Publicado: (2014)

Randomised controlled trial comparing hypnotherapy versus gabapentin for the treatment of hot flashes in breast cancer survivors: a pilot study
por: MacLaughlan David, Shannon, et al.
Publicado: (2013)

Role of miRNAs interference on ovarian functions and premature ovarian failure
por: Nouri, Narjes, et al.
Publicado: (2022)

Increased Local Testosterone Levels Alter Human Fallopian Tube mRNA Profile and Signaling
por: Russo, Angela, et al.
Publicado: (2023)

Mechanisms of Regulation of the Expression of miRNAs and lncRNAs by Metformin in Ovarian Cancer
por: Alfaro, Ignacio, et al.
Publicado: (2023)

Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells
por: Kim, Kyu Kwang, et al.
Publicado: (2010)

Plasma miRNAs as Diagnostic and Prognostic Biomarkers for Ovarian Cancer
por: Zheng, Hong, et al.
Publicado: (2013)

The clinical impact of intra‐ and extracellular miRNAs in ovarian cancer
por: Yoshida, Kosuke, et al.
Publicado: (2020)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

Advances of exosomal miRNAs in the diagnosis and treatment of ovarian cancer
por: Xiong, Jun, et al.
Publicado: (2023)

The differential expression of miRNAs between ovarian endometrioma and endometriosis-associated ovarian cancer
por: Nakamura, Natsuho, et al.
Publicado: (2020)

Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma
por: Bowden, Michaela, et al.
Publicado: (2017)

Circulating miRNAs as a marker of metastatic disease and prognostic factor in metastatic breast cancer
por: Papadaki, Chara, et al.
Publicado: (2019)

Plasma exosomal miRNAs-based prognosis in metastatic kidney cancer
por: Du, Meijun, et al.
Publicado: (2017)

Identification of miRNAs during mouse postnatal ovarian development and superovulation
por: Khan, Hamid Ali, et al.
Publicado: (2015)

A combination of circulating miRNAs for the early detection of ovarian cancer
por: Yokoi, Akira, et al.
Publicado: (2017)

Integrated bioinformatics analysis of validated and circulating miRNAs in ovarian cancer
por: Dogan, Berkcan, et al.
Publicado: (2022)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

Identification of keygenes, miRNAs and miRNA-mRNA regulatory pathways for chemotherapy resistance in ovarian cancer
por: Wang, Wenwen, et al.
Publicado: (2021)

Comprehensive analysis of mRNAs and miRNAs in the ovarian follicles of uniparous and multiple goats at estrus phase
por: Zou, Xian, et al.
Publicado: (2020)

The intestinal microbiota influences the microenvironment of metastatic colon cancer by targeting miRNAs
por: Zhou, Shihai, et al.
Publicado: (2022)

Evaluation of the cytotoxicity of the Bithionol - cisplatin combination in a panel of human ovarian cancer cell lines
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2017)

Evaluation of the cytotoxicity of the Bithionol-paclitaxel combination in a panel of human ovarian cancer cell lines
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2017)

Comprehensive analysis on diagnostic value of circulating miRNAs for patients with ovarian cancer
por: Wang, Huiqing, et al.
Publicado: (2017)

Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer
por: Prahm, Kira Philipsen, et al.
Publicado: (2018)

Circulating miRNAs as Biomarkers for Endometriosis and Endometriosis-Related Ovarian Cancer—An Overview
por: Moga, Marius Alexandru, et al.
Publicado: (2019)

Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer
por: Retamales-Ortega, Rocío, et al.
Publicado: (2017)

The Ratio of Toxic-to-Nontoxic miRNAs Predicts Platinum Sensitivity in Ovarian Cancer
por: Patel, Monal, et al.
Publicado: (2021)

Evaluation of Diagnostic Potential of Epigenetically Deregulated MiRNAs in Epithelial Ovarian Cancer
por: Kumar, Vivek, et al.
Publicado: (2021)

Circulating non-coding RNAs in recurrent and metastatic ovarian cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2019)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
por: Kim, Kyu Kwang, et al.
Publicado: (2012)

Assessment of acyl-CoA cholesterol acyltransferase (ACAT-1) role in ovarian cancer progression—An in vitro study
por: Ayyagari, Vijayalakshmi N., et al.
Publicado: (2020)

Comparative Analysis of Differentially Expressed miRNAs and their Downstream mRNAs in Ovarian Cancer and its Associated Endometriosis
por: Wu, Richard Licheng, et al.
Publicado: (2015)

Ovarian transcriptomic study reveals the differential regulation of miRNAs and lncRNAs related to fecundity in different sheep
por: Miao, Xiangyang, et al.
Publicado: (2016)

Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6g70q8ocu4dbjhmb6gn5dap1bn